Newsroom

To Get in Touch with DLC:

Media (@) Diabetes Leadership (DOT) org

Hot Topics

DLC Brief: Type 1 Diabetes Screening
News Outlet: 
This is some text inside of a div block.
Read More
DLC and DPAC Joint Statement on Congress' End of Year Spending Package
News Outlet: 
This is some text inside of a div block.
Read More
DLC and DPAC Joint Statement on the FTC’s Case Against Pharmacy Benefit Managers (PBMs)
News Outlet: 
This is some text inside of a div block.
Read More
Report
Consensus Statement: Towards the standardisation of adult person-reported outcome domains in diabetes research
News Outlet: 
This is some text inside of a div block.
Read More
Release
The Diabetes Leadership Council Recognizes Three Congressional Leaders as Diabetes Champions
News Outlet: 
This is some text inside of a div block.
Read More
Letter
DLC and DPAC issue joint statement on Tennessee decision to reject legislation that would cap insulin costs
News Outlet: 
This is some text inside of a div block.
Read More

In The News

Release
INSULIN Act Gains Momentum with Bipartisan House Introduction
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Letter
DLC and DPAC Respond to CMS Proposed Rule to Reiterate Patient Disruptions to come from the Competitive Bidding Program for CGMs and Insulin Pumps.
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Letter
DLC and DPAC Respond to Senate HELP Committee's 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Letter
Response to the Senate Finance Committee Minority Staff Request for Information, “Commonsense Policy Options to Lower Drug Prices for Patients”
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
DLC and DPAC Applaud House Appropriations Committee for Acting to Protect Access to Lifesaving Diabetes Technology
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Report
2026 DLC Annual Report
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
INSULIN Act Introduced to ImproveAccess and Affordability of Insulin for People with Diabetes
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
Diabetes Leadership Council and Diabetes Patient Advocacy Coalition Urge CMS to Enforce Court Decision on Copay Accumulator Policies in Response to Proposed Marketplace Regulation
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
Sens. Shaheen & Collins Introduce Legislation to Improve Access to Diabetes Technology and Education for Medicare Beneficiaries
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
DLC leads consensus statement on diabetes health care reform
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
Diabetes Leadership Council and Diabetes Patient Advocacy Coalition: Our Advocacy Continues after Positive First Steps in PBM Reform
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
DPAC and DLC Respond to Administration’s “Great Healthcare Plan” and Call for Urgent PBM Reform
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
New Model to Expand Access to Obesity Treatments is a Positive Step Toward Better Obesity Care for Patients
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
The Diabetes Leadership Council Announces 2026 Board of Directors
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Release
DLC and DPAC: Patients will Be Negatively Impacted by Changes to CGM & Insulin Pump Delivery in Medicare
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Diabetes Leadership Council Calls for Expanded Patient Choice in Diabetes Technologies to Improve Outcomes and Equity
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
DLC and DPAC Respond to Section 232 Investigation on Pharmaceuticals
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF
Letter
DLC/DPAC Letter to HHS and NIH on the Importance of DPPOS Funding
News Outlet: 
This is some text inside of a div block.
Read MoreView Article
PDF

Statements and Letters

Letter
Sharps Disposal
News Outlet: 
This is some text inside of a div block.
Read More
PDF
Letter
Letter to CMS: Chronic Kidney Disease Treatment
News Outlet: 
This is some text inside of a div block.
Read More
PDF

Fast Facts

#7
Diabetes is the seventh leading cause of death in the U.S. and is likely underreported
1 in 3
People with prediabetes do not know they have it
1 in 5
People with diabetes do not know they have it
90-95%
People with diabetes who have type 2 diabetes
5-10%
People with diabetes who have type 1 diabetes
122 MILLION
Americans with diabetes
2.3x
Higher higher average medical costs for a person with diabetes compared to a person without diabetes
$16,750
Annual average medical spending for a person with diabetes, of which $9,600 is directly attributed to diabetes
$1 in $4
U.S. health care dollars related to diabetes
$237 BILLION
Direct medical costs related to diagnosed diabetes in the U.S. (in 2017, now more than $260 billion inflation adjusted to 2021)
$327 BILLION
Total estimated cost of diagnosed diabetes in the U.S. (2017)
#7
Diabetes is the seventh leading cause of death in the U.S. and is likely underreported
1 in 3
People with prediabetes do not know they have it
1 in 5
People with diabetes do not know they have it
90-95%
People with diabetes who have type 2 diabetes
5-10%
People with diabetes who have type 1 diabetes
122 MILLION
Americans with diabetes
2.3x
Higher higher average medical costs for a person with diabetes compared to a person without diabetes
$16,750
Annual average medical spending for a person with diabetes, of which $9,600 is directly attributed to diabetes
$1 in $4
U.S. health care dollars related to diabetes
$237 BILLION
Direct medical costs related to diagnosed diabetes in the U.S. (in 2017, now more than $260 billion inflation adjusted to 2021)
$327 BILLION
Total estimated cost of diagnosed diabetes in the U.S. (2017)

Policy Recommendations to Improve U.S. Health Care

Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.

Download Our Consensus Statement